Vimian Group Revenue and Competitors
Employee Data
- Vimian Group has 28 Employees.
- Vimian Group grew their employee count by 8% last year.
Vimian Group's People
Name | Title | Email/Phone |
---|
Vimian Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 205 | 6% | N/A | N/A |
#2 | N/A | 28 | 8% | N/A | N/A |
What Is Vimian Group?
Vimian is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to animals and veterinary professionals around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential areas within animal health: Specialty Pharma (www.nextmune.com), Diagnostics (www.indical.com), Veterinary Services (www.vetfamily.com) and MedTech (www.movora.com). Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies serve over 15,000 customers in +70 countries and employ more than 400 people.
keywords:N/AN/A
Total Funding
28
Number of Employees
N/A
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vimian Group News
Looking forward, IMARC Group expects the market to reach a value of US$ 59.37 Billion by 2027, ... INDICAL Bioscience GmbH (Vimian Group)
One way to conceptualize this is that for each SEK1 of shareholders' capital it has, the company made SEK0.02 in profit. Does Vimian Group Have...
Vimian Group's Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 28 | 33% | N/A |
#2 | N/A | 28 | 0% | N/A |
#3 | $3.5M | 28 | -3% | N/A |
#4 | N/A | 28 | 56% | N/A |
#5 | $4.4M | 28 | -26% | N/A |